Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy-Reference-Cited by-同舟云学术

Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy

Published:2012-07 Issue:4 Volume:8 Page:e32-e39
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Hwang Jessica P.¹,Fisch Michael J.¹,Zhang Hong¹,Kallen Michael A.¹,Routbort Mark J.¹,Lal Lincy S.¹,Vierling John M.¹,Suarez-Almazor Maria E.¹

Affiliation:

1. The University of Texas MD Anderson Cancer Center; Ingenix Consulting; and Baylor College of Medicine, Houston, TX

Abstract

Future research directed toward identifying best screening methods and HBV risk tools will be necessary to reduce the risk of reactivation of HBV infection after chemotherapy.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2011.000450

Reference43 articles.

1. Reactivation of hepatitis B

2. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

3. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy

4. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study

5. The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients;Supportive Care in Cancer;2024-07-24

2. Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis;Asia-Pacific Journal of Clinical Oncology;2024-03-21

3. Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients;2024-02-05

4. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs;Arthritis Care & Research;2023-08-29

5. Tedavide biyolojik ajanlar kullanan hekimlerin hepatit B virüs reaktivasyonu konusundaki farkındalıkları;Journal of Biotechnology and Strategic Health Research;2023-04-30